The hippocampus is one of the first regions to demonstrate atrophy during the prodromal
stage of Alzheimer's disease. Volumetric analysis of its individual subfields could provide …

Accumulating evidence suggests vascular dysregulation in preclinical Alzheimer’s disease.
In this study, cerebral hemodynamics and their coupling with cognition in middle-aged …

Cerebral hemodynamic alterations have been observed in apolipoprotein ε4 (APOE4)
carriers at midlife, however the physiological underpinnings of this observation are poorly …

Sensitive and specific antemortem biomarkers of neurodegenerative disease and dementia
are crucial to the pursuit of effective treatments, required both to reliably identify disease and …

White matter hyperintensities are common radiological findings in ageing and a typical
manifestation of cerebral small vessel disease. White matter hyperintensity burden is evaluated …

Background Considerable overlap exists between the risk factors of dementia and cerebral
small vessel disease (SVD). However, studies remain limited to older cohorts wherein …

Background Macrostructural brain alterations in the form of brain atrophy or cortical thinning
typically occur during the prodromal Alzheimer’s disease stage. Mixed findings largely …

Abstract Changes in the brain’s physiology in Alzheimer’s disease are thought to occur
early in the disease’s trajectory. In this study our aim was to investigate the brain’s …

Functional brain connectivity of the resting-state networks has gained recent attention as a
possible biomarker of Alzheimer’s Disease (AD). In this paper, we review the literature of …

The apolipoprotein E ɛ4 allele is the primary genetic risk factor for the sporadic type of
Alzheimer’s disease. However, the mechanisms by which apolipoprotein E ɛ4 are associated …